UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 119

Sortiert nach

Bioanalytical methods for the quantification of hydromorphone, fentanyl, norfentanyl, morphine, morphine-3ß-glucuronide and morphine-6ß-glucuronide in human plasma

Journal of pharmaceutical and biomedical analysis, 2018-02, Vol.149, p.475-481

2018

Volltextzugriff (PDF)

Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2011-12, Vol.56 (5), p.1016-1023

2011

Volltextzugriff (PDF)

Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial

Clinical pharmacology and therapeutics, 2022-02, Vol.111 (2), p.455-460

2022

Volltextzugriff (PDF)

Effects of Protein and Calorie Restriction on the Metabolism and Toxicity Profile of Irinotecan in Cancer Patients

Clinical pharmacology and therapeutics, 2021-05, Vol.109 (5), p.1304-1313

2021

Volltextzugriff (PDF)

Influence of darolutamide on cabazitaxel systemic exposure

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5038-5038

2022

Volltextzugriff (PDF)

Quantitation of osimertinib, alectinib and lorlatinib in human cerebrospinal fluid by UPLC-MS/MS

Journal of pharmaceutical and biomedical analysis, 2023-02, Vol.225, p.115233, Article 115233

2023

Volltextzugriff (PDF)

Influence of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib: A Randomized Crossover Pharmacokinetic Study

Clinical pharmacology and therapeutics, 2019-06, Vol.105 (6), p.1456-1461

2019

Volltextzugriff (PDF)

Quantification and clinical validation of the selective MET kinase inhibitor DO-2 and its metabolites DO-5 and M3 in human plasma

Journal of pharmaceutical and biomedical analysis, 2024-03, Vol.240, p.115962, Article 115962

2024

Volltextzugriff (PDF)

Fasting protects against the side effects of irinotecan treatment but does not affect anti‐tumour activity in mice

British journal of pharmacology, 2016-03, Vol.173 (5), p.804-814

2016

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer

Clinical pharmacokinetics, 2022-04, Vol.61 (4), p.527-537

2022

Volltextzugriff (PDF)

The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study

Clinical pharmacokinetics, 2024-07, Vol.63 (7), p.1037-1044

2024

Volltextzugriff (PDF)

Influence of Darolutamide on Cabazitaxel Systemic Exposure

Clinical pharmacokinetics, 2022-10, Vol.61 (10), p.1471-1473

2022

Volltextzugriff (PDF)

Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation

The Prostate, 2016-07, Vol.76 (10), p.927-936

2016

Volltextzugriff (PDF)

To quantify the small-molecule kinase inhibitors ceritinib, dacomitinib, lorlatinib, and nintedanib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2021-01, Vol.193, p.113733-113733, Article 113733

2021

Volltextzugriff (PDF)

Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug–drug interaction study

British journal of clinical pharmacology, 2019-05, Vol.85 (5), p.986-992

2019

Volltextzugriff (PDF)

Nanoparticle entrapped docetaxel (CPC634) enhances intratumoral docetaxel exposure compared to conventional docetaxel (Cd) in patients with solid tumors

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.3096-3096

2019

Volltextzugriff (PDF)

Quantification of ribociclib in dried blood spots by LC–MS/MS: Method development and clinical validation

Journal of pharmaceutical and biomedical analysis, 2021-07, Vol.201, p.114118-114118, Article 114118

2021

Volltextzugriff (PDF)

Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifen

British journal of clinical pharmacology, 2014-09, Vol.78 (3), p.572-586

2014

Volltextzugriff (PDF)

Quantification of the tyrosine kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: Pitfalls for clinical application

Journal of pharmaceutical and biomedical analysis, 2019-08, Vol.172, p.175-182

2019

Volltextzugriff (PDF)

Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure

Clinical pharmacokinetics, 2017-03, Vol.56 (3), p.305-310

2017

Volltextzugriff (PDF)

Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch

Clinical pharmacokinetics, 2016-02, Vol.55 (2), p.249-255

2016

Volltextzugriff (PDF)

A drug-drug interaction study on the combination of cabazitaxel with enzalutamide in patients with metastatic castration-resistant prostate cancer

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.188-188

2017

Volltextzugriff (PDF)

Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical Evidence

Clinical pharmacokinetics, 2015-08, Vol.54 (8), p.851-858

2015

Volltextzugriff (PDF)

Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS G12C -Mutated NSCLC Treated With Sotorasib

Journal of thoracic oncology, 2024-04

2024

Volltextzugriff (PDF)

Development and validation of an UPLC–MS/MS method for the quantification of tamoxifen and its main metabolites in human scalp hair

Journal of pharmaceutical and biomedical analysis, 2015-10, Vol.114, p.416-425

2015

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Aktive Filter

ThemaAged, 80 And Over

ThemaOncology

KollektionOvid SocietyJournals and Single Titles

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(104)

Publikationsform

Artikel
(118)
Tagungsberichte
(1)

Sprache

Englisch
(119)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(76)
Life Sciences & Biomedicine
(71)
Humans
(50)
Female
(36)
Male
(36)
Aged
(26)
Middle Aged
(25)
Pharmacology & Pharmacy
(24)
Neurosciences & Neurology
(21)
Clinical Neurology
(20)
Biological And Medical Sciences
(19)
Neurology
(14)
Cardiovascular System & Cardiology
(13)
Medical Sciences
(13)
Physical Sciences
(13)
Treatment Outcome
(12)
Chemistry
(11)
Chemistry, Analytical
(11)
Fundamental And Applied Biological Sciences. Psychology
(11)
Peripheral Vascular Disease
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Bioanalytical methods for the quantification of hydromorphone, fentanyl, norfentanyl, morphine, morphine-3ß-glucuronide and morphine-6ß-glucuronide in human plasma

Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry

Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial

Effects of Protein and Calorie Restriction on the Metabolism and Toxicity Profile of Irinotecan in Cancer Patients

Influence of darolutamide on cabazitaxel systemic exposure

Quantitation of osimertinib, alectinib and lorlatinib in human cerebrospinal fluid by UPLC-MS/MS

Influence of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib: A Randomized Crossover Pharmacokinetic Study

Quantification and clinical validation of the selective MET kinase inhibitor DO-2 and its metabolites DO-5 and M3 in human plasma

Fasting protects against the side effects of irinotecan treatment but does not affect anti‐tumour activity in mice

Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer

The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study

Influence of Darolutamide on Cabazitaxel Systemic Exposure

Understanding taxanes in prostate cancer; importance of intratumoral drug accumulation

To quantify the small-molecule kinase inhibitors ceritinib, dacomitinib, lorlatinib, and nintedanib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry

Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug–drug interaction study

Nanoparticle entrapped docetaxel (CPC634) enhances intratumoral docetaxel exposure compared to conventional docetaxel (Cd) in patients with solid tumors

Quantification of ribociclib in dried blood spots by LC–MS/MS: Method development and clinical validation

Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifen

Quantification of the tyrosine kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: Pitfalls for clinical application

Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure

Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch

A drug-drug interaction study on the combination of cabazitaxel with enzalutamide in patients with metastatic castration-resistant prostate cancer

Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical Evidence

Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS G12C -Mutated NSCLC Treated With Sotorasib

Development and validation of an UPLC–MS/MS method for the quantification of tamoxifen and its main metabolites in human scalp hair

Aktive Filter

Suchergebnisse filtern